Transbronchial lung cryobiopsy in the diagnosis of interstitial lung disease

Research output: Contribution to journalReview articlepeer-review

Abstract

Transbronchial cryoprobe lung biopsy (TBCLB) have recently been introduced as a safe diagnostic tool in the diagnosis of interstitial lung diseases. While we do not enough evidence its role and place as a diagnostic procedure, the technique has been adopted by many centers. In spite of expanding body of literature, there are variations in patient selection and procedural aspect of the procedure. It has been established as a safe procedure if safety measures are practiced. Diagnosis of interstitial lung diseases continuous to be challenging. Surgical lung biopsy considered as gold standard but its morbidity and mortality limit its utilization in every case. Multidisciplinary medical decision is a validated team work effort when approaching patients with interstitial lung disease.

Original languageEnglish (US)
Pages (from-to)300-306
Number of pages7
JournalTuberkuloz ve Toraks
Volume67
Issue number4
DOIs
StatePublished - 2019

Bibliographical note

Publisher Copyright:
© 2019 by Tuberculosis and Thorax.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cryobiopsy
  • Interstitial lung disease
  • Transbronchial

Fingerprint

Dive into the research topics of 'Transbronchial lung cryobiopsy in the diagnosis of interstitial lung disease'. Together they form a unique fingerprint.

Cite this